Abrams, B., & Selvin, S. (1995). Maternal weight gain pattern and birth weight. Obstetrics and Gynecology, 86, 163.

American College of Obstetricians and Gynecologists. (1995a). Folic acid for the prevention of recurrent neural tube defects (ACOG Committee Opinion 120). Washington, DC: Author.

American College of Obstetricians and Gynecologists. (1995b). Guidelines for diagnostic imaging during pregnancy (ACOG Committee Opinion 158). Washington, DC: Author.

Azais-Braesco, V., & Pascal, G. (2000). Vitamin A in pregnancy: Requirements and safety limits. American Journal of Clinical Nutrition, 71(5, Suppl.), 1325S-1333S.

Beckman, A.A., & Brent, R.L. (1986). Mechanism of known environmental teratogens: Drugs and chemicals. Clinics in Perinatology, 13, 649-687.

Brent, R.L. (1999). The effect of embryonic and fetal exposure to x-ray, microwaves, and ultrasound: reproductive risks from pre-and post-conception environmental radiation exposures. Teratology, 59, 182.

Butters, L., Kennedy, S., & Rubin, P.C. (1990). Atenolol in essential hypertension during pregnancy. British Medical Journal, 301, 587-590.

Casey, B.M., Lucas, M.J., McIntire, D.D., et al. (1997). Pregnancy outcomes in women with gestational diabetes compared with the general obstetric population. Obstetrics and Gynecology, 90, 869-873.

Centers for Disease Control. (1992). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR, 41(RR-14), 1-7.

Centers for Disease Control and Prevention. (1998). Guidelines for the treatment of sexually transmitted diseases. MMWR, 47(RR-1), 28-48.

Cunningham, F.G., MacDonald, P.C., Leveno, K.J., et al. (2001). Williams obstetrics (21st ed.). New York: McGrawHill.

Decoufle, P., Boyle, C.A., Paulozzi, L.J., et al. (2001). Increased risk for developmental disabilities in children who have major birth defects: A population-based study. Pediatrics, 108, 728-734.

Gililland, J., & Weinstein, L. (1983). The effects of cancer chemotherapeutic agents on the developing fetus. Obstetrical and Gynecological Survey, 38, 6-13.

Haddow, J.E., Palomaki, G.E., Allan, W.C., et al. (1999). Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. New England Journal of Medicine, 341, 549-555.

Hall, E.J. (1991). Scientific view of low-level radiation risks. Radiographics, 11, 509.

Hay, W.W., Catz, C.S., Grave, G.D., et al. (1997). Workshop summary: fetal growth: Its regulation and disorders. Journal of Pediatrics, 99, 585-592.

Hernandez-Diaz, S., Werler, M.M., Walker, A.M., et al. (2000). Folic acid antagonists during pregnancy and the risk of birth defects. New England Journal of Medicine, 343, 1608-1614.

Holmes, L.B., Harvey, E.A., & Coull, B.A. (2001). The teratogenicity of anticonvulsant drugs. New England Journal of Medicine, 344, 1132-1138.

Institute of Medicine. (1990). Nutrition during pregnancy. Washington, DC: National Academy Press.

Kaneko, S., Otani, K., Fukushima, Y., et al. (1988). Teratogenicity of anti-epileptic drugs: Analysis of possible risk factors. Epilepsia, 29, 459-467.

Moore, K.L., & Persaud, T.V.N. (1993). Before we are born: Essentials of embryology and birth defects. Philadelphia: W.B. Saunders.

Mulder, J.E. (1998). Thyroid disease in women. Medical Clinics of North America, 82, 104-125.

Nakane, Y., Okuma, T., Takahashi, R., et al. (1980). Multi-institutional study on the teratogenicity and fetal toxicity of anti-epileptic drugs: a report of collaborative study group in Japan. Epilepsia, 21, 663-380.

Newman, C.G. (1985). Teratogen update: clinical aspects of thalidomide embryopathy. A continuing preoccupation. Teratology, 32, 133-144.

Noyola, D.E., Demmler, G.J., Nelson, C.T., et al. (2001). Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. Journal of Pediatrics, 138, 324-331.

Peaceman, A.M., & Ramsey-Goldman, R. (2001). Autoimmune connective tissue disease in pregnancy. Sciarra’s Obstetrics and Gynecology, 3(20), 1-5.

Rosa, F.W. (1991). Spina bifida in infants of women treated with carbamazepine during pregnancy. New England Journal of Medicine, 324, 674-677.

Rothman, K.J., Moore, L.L., Singer, M.R., et al. (1995). Teratogenicity of high vitamin A intake. New England Journal of Medicine, 333, 1369.

Sibai, B. (1996). Treatment of hypertension in pregnant women. New England Journal of Medicine, 335, 257-265.

Smith, G., Smith, M., McNay, M.B., et al. (1998). First trimester growth and the risk of low birth weight. New England Journal of Medicine, 339, 1817-1822.

Taussig, H.B. (1962). Thalidomide: A lesson in remote effects of drugs. American Journal of Diseases of Children, 104, 111-113.

Willhoite, M.B., Benvert, H.W., Palomaki, G.E., et al. (1993). The impact of preconception counseling on pregnancy outcomes: The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care, 16, 450-455.